Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goldstone

Showing results (161-170 of 311) with videos related to

Pageof 32
Sort By:
Cancer|February 23, 2007
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatmentAlan K Burnett, Donald Milligan, Archie G Prentice, et al.
Lancet (London, England)|March 21, 1998
Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working PartiesA K Burnett, A H Goldstone, R M Stevens, et al.
British Journal of Haematology|March 1, 1983
T cell regeneration after allogeneic and autologous bone marrow transplantationD C Linch, L J Knott, R M Thomas, et al.
Molecular Microbiology|June 5, 2007
A functionally divergent hydrogenosomal peptidase with protomitochondrial ancestryMark T Brown, Heather M H Goldstone, Felix Bastida-Corcuera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphomaM J Watts, A M Sullivan, E Jamieson, et al.
Gene Therapy|June 6, 1998
Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphomaS Devereux, C Corney, C Macdonald, et al.
British Journal of Haematology|November 25, 2010
Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%Sajir G Mohamedbhai, Keith Sibson, Teresa Marafioti, et al.
Blood|March 1, 1993
The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patientsR Chopra, A K McMillan, D C Linch, et al.
Journal of Virological Methods|June 1, 1996
Hepatitis B nucleotide sequence analysis: linking an outbreak of acute hepatitis B to contamination of a cryopreservation tankA E Hawkins, M A Zuckerman, M Briggs, et al.
Blood|April 1, 1997
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research CouncilI M Hann, R F Stevens, A H Goldstone, et al.
Pageof 32

Showing results (161-170 of 311) with videos related to

Sort By:
Pageof 32
Cancer|February 23, 2007
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatmentAlan K Burnett, Donald Milligan, Archie G Prentice, et al.
Lancet (London, England)|March 21, 1998
Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working PartiesA K Burnett, A H Goldstone, R M Stevens, et al.
British Journal of Haematology|March 1, 1983
T cell regeneration after allogeneic and autologous bone marrow transplantationD C Linch, L J Knott, R M Thomas, et al.
Molecular Microbiology|June 5, 2007
A functionally divergent hydrogenosomal peptidase with protomitochondrial ancestryMark T Brown, Heather M H Goldstone, Felix Bastida-Corcuera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphomaM J Watts, A M Sullivan, E Jamieson, et al.
Gene Therapy|June 6, 1998
Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphomaS Devereux, C Corney, C Macdonald, et al.
British Journal of Haematology|November 25, 2010
Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%Sajir G Mohamedbhai, Keith Sibson, Teresa Marafioti, et al.
Blood|March 1, 1993
The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patientsR Chopra, A K McMillan, D C Linch, et al.
Journal of Virological Methods|June 1, 1996
Hepatitis B nucleotide sequence analysis: linking an outbreak of acute hepatitis B to contamination of a cryopreservation tankA E Hawkins, M A Zuckerman, M Briggs, et al.
Blood|April 1, 1997
Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research CouncilI M Hann, R F Stevens, A H Goldstone, et al.
Pageof 32